Zacks Investment Research on MSN7d
Here's Why Moderna Stock Soared 16% on Wednesday
Shares of Moderna MRNA rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on ...
The Pharma Letter7d
FDA places clinical hold on BioNTech malaria trial
German biotech major BioNTech (Nasdaq: BNTX) has suffered a blow as it seeks to add new revenue streams beyond its COVID-19 ...
Berenberg Bank Sticks to Its Buy Rating for BioNTech SE (BNTX)
In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...
FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine
BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with ...
The Pharma Letter7d
US Patent Board invalidates Moderna vaccine IP
The US Patent Trial and Appeal Board handed a massive victory to Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) on Wednesday, ...
BNTX Insider Trade Alert! Co-Founder and CEO Sells BioNTech Stock Worth $119M
Ugur Sahin, the co-founder and CEO of BioNTech SE (BNTX), sold $119.58 million worth of the Germany-based biotechnology company’s stock last ...
Reuters on MSN8d
Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rules
The court said Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that ...
Morningstar10d
BioNTech SE ADR BNTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Yahoo Finance28d
What Makes BioNTech (BNTX) a New Buy Stock
Investors might want to bet on BioNTech SE Sponsored ADR (BNTX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...